GlobeNewswire: Adherium North America Inc Contains the last 10 of 20 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T15:15:41ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/10/25/1627595/0/en/Adherium-Announces-Q1-Fiscal-Year-2019-Investor-Conference-Call.html?f=22&fvtc=4&fvtv=39471Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call2018-10-25T22:06:58Z<![CDATA[SAN MATEO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Tuesday, October 30, 2018 at 6.30pm ET to discuss first quarter fiscal year 2019 results and business update. Arik Anderson, Chief Executive Officer will host the call and will be joined by Adherium’s Chief Financial Officer, David Allinson.]]>https://www.globenewswire.com/news-release/2018/10/03/1600585/0/en/Adherium-Announces-Participation-in-SmartAirLA-Effort-to-Combat-Asthma-in-Los-Angeles-with-Support-from-Blue-Shield-of-California-Foundation.html?f=22&fvtc=4&fvtv=39471Adherium Announces Participation in SmartAirLA Effort to Combat Asthma in Los Angeles with Support from Blue Shield of California Foundation2018-10-03T10:00:00Z<![CDATA[The Program Aims In Part to Develop Better Models for Expanding Data-Based Medication Adherence The Program Aims In Part to Develop Better Models for Expanding Data-Based Medication Adherence]]>https://www.globenewswire.com/news-release/2018/08/23/1555641/0/en/Adherium-and-Vitalus-Health-Launch-Commercial-Program-to-Support-Patients-with-Asthma-and-COPD.html?f=22&fvtc=4&fvtv=39471Adherium and Vitalus Health Launch Commercial Program to Support Patients with Asthma and COPD2018-08-23T10:00:00Z<![CDATA[SAN MATEO, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR) a digital health platform focused on improving medication adherence and patient outcomes, and Vitalus Health, a leading provider of comprehensive health and wellness solutions that focus on pulmonary disease management, today announced a broadened strategic program encompassing Adherium’s Hailie™ solution.]]>https://www.globenewswire.com/news-release/2018/08/13/1550687/0/en/Adherium-Launches-Hailie-Solution-Direct-to-Consumer-in-the-U-S-for-Better-Asthma-and-COPD-Management.html?f=22&fvtc=4&fvtv=39471Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management2018-08-13T10:00:00Z<![CDATA[SAN MATEO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX: ADR), a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the Hailie™ solution in the U.S., following its recent Food and Drug Administration (FDA) 510(k) over-the-counter clearance to enable sales direct to consumers. The Hailie solution helps patients with asthma and COPD access better care through a seamless digital experience that includes a smartphone app, available on both iOS and Android, and a sensor that attaches to patient’s prescription inhaler medication.]]>https://www.globenewswire.com/news-release/2018/07/26/1543137/0/en/Adherium-Receives-Additional-U-S-FDA-510-k-Clearance-Setting-in-Motion-a-Full-U-S-Consumer-Launch-of-the-Hailie-Solution.html?f=22&fvtc=4&fvtv=39471Adherium Receives Additional U.S. FDA 510(k) Clearance, Setting in Motion a Full U.S. Consumer Launch of the Hailie™ Solution2018-07-26T22:34:37Z<![CDATA[SAN MATEO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health platform that improves medication adherence, patient outcomes and engagement, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for over-the-counter (OTC) sales of its Hailie™ sensor for use with ProAir® HFA, Ventolin® HFA and Flovent® HFA asthma inhalers.]]>https://www.globenewswire.com/news-release/2018/07/10/1535464/0/en/Adherium-Announces-Patient-Program-with-Connecticut-Children-s-Medical-Center-to-Explore-Best-Practices-for-Access-to-Better-Asthma-Care-Nationally.html?f=22&fvtc=4&fvtv=39471Adherium Announces Patient Program with Connecticut Children’s Medical Center to Explore Best Practices for Access to Better Asthma Care Nationally2018-07-10T14:13:28Z<![CDATA[SAN MATEO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a leading digital health company that improves medication adherence and patient outcomes, today announced a patient program with Connecticut Children’s Medical Center to help patients with asthma manage their condition with Adherium’s technology, the Hailie™ solution.]]>https://www.globenewswire.com/news-release/2018/05/24/1511495/0/en/Adherium-Announces-Appointment-of-David-Allinson-as-Chief-Financial-Officer.html?f=22&fvtc=4&fvtv=39471Adherium Announces Appointment of David Allinson as Chief Financial Officer2018-05-24T12:00:00Z<![CDATA[SAN MATEO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced that David Allinson has joined the Company as Chief Financial Officer, effective immediately.]]>David Allinson brings 20+ years of executive-level financial leadership to Adherium in Chief Financial Officer role.David Allinson, CFO of Adheriumhttps://www.globenewswire.com/news-release/2018/05/18/1509008/0/en/Adherium-s-Technology-Used-for-Large-Scale-Electronic-Data-Capture-in-Landmark-Mild-Asthma-Trials.html?f=22&fvtc=4&fvtv=39471Adherium’s Technology Used for Large Scale Electronic Data Capture in Landmark Mild-Asthma Trials2018-05-18T18:04:15Z<![CDATA[SAN MATEO, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it’s Hailie™ (previously known as Smartinhaler™) technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal of Medicine and will be presented this weekend at the American Thoracic Society’s 2018 Congress.]]>Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaThe New England Journal of Medicinehttps://www.globenewswire.com/news-release/2018/05/16/1507685/0/en/Adherium-Launches-the-Hailie-Global-Brand-to-Connect-People-with-Asthma-and-COPD-to-Better-Care.html?f=22&fvtc=4&fvtv=39471Adherium Launches the Hailie™ Global Brand to Connect People with Asthma and COPD to Better Care2018-05-16T19:00:00Z<![CDATA[SAN MATEO, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the Hailie™ global brand to connect people with asthma and COPD to better care. The launch is a rebrand of the existing Smartinhaler™ brand, and includes the free Hailie™ app, an asthma and COPD tracking solution available on both iOS and Android, ultimately setting the stage for availability of Hailie™ sensors to consumers in the U.S.]]>https://www.globenewswire.com/news-release/2018/05/15/1502516/0/en/Adherium-to-Present-at-the-Chardan-Digital-Health-Conference-on-Tuesday-May-22-2018.html?f=22&fvtc=4&fvtv=39471Adherium to Present at the Chardan Digital Health Conference on Tuesday, May 22, 20182018-05-15T12:00:00Z<![CDATA[SAN MATEO, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence and patient outcomes, today announced the Company will be participating in the upcoming Chardan Digital Health Conference in San Francisco, CA on Tuesday, May 22, 2018.]]>